Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) - Total Liabilities
Latest total liabilities as of September 2025: CN¥700.20 Million CNY
Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has total liabilities worth CN¥700.20 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Total Liabilities Trend (2016–2024)
This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Freewon China Co. Ltd. A
SHG:688678
|
China | CN¥2.23 Billion |
|
Minera Frisco S.A.B. de C.V
PINK:MFRVF
|
USA | $22.53 Billion |
|
WEB Travel Group Ltd
AU:WEB
|
Australia | AU$1.10 Billion |
|
Tianjin Printronics Circuit Corp
SHE:002134
|
China | CN¥1.33 Billion |
|
Jiangxi Guotai Civilian
SHG:603977
|
China | CN¥2.43 Billion |
|
Austal Limited
PINK:AUTLF
|
USA | $1.64 Billion |
|
Worldline SA
PINK:WWLNF
|
USA | $11.00 Billion |
|
Brim hf
IC:BRIM
|
Iceland | Ikr477.84 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2024)
The table below shows the annual total liabilities of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥334.27 Million | +35.69% |
| 2023-12-31 | CN¥246.35 Million | +93.99% |
| 2022-12-31 | CN¥126.99 Million | +60.65% |
| 2021-12-31 | CN¥79.05 Million | -45.45% |
| 2020-12-31 | CN¥144.91 Million | -7.87% |
| 2019-12-31 | CN¥157.28 Million | +45.50% |
| 2018-12-31 | CN¥108.09 Million | -42.92% |
| 2017-12-31 | CN¥189.38 Million | -29.64% |
| 2016-12-31 | CN¥269.14 Million | -- |